Search the Newsreel

Myriad Debuts FirstGene Four-in-One Prenatal Genetic Screening From Single Blood Sample

Myriad Genetics has launched FirstGene Multiple Prenatal Screen, a new laboratory test that performs four prenatal genetic screens from a single maternal blood draw as early as eight weeks of pregnancy. This innovative test combines fetal chromosome, fetal single-gene, patient carrier, and fetal RhD …

Myriad Genetics Launches New Four-in-One Prenatal Genetic Screen

Myriad Genetics has announced the full commercial launch of its FirstGene Multiple Prenatal Screen, a new laboratory test capable of performing four prenatal genetic screens from a single blood sample as early as eight weeks gestation. The test integrates fetal chromosome, fetal single-gene, patient …

Myriad's one-draw test runs four prenatal screens at 8 weeks

Myriad Genetics has launched FirstGene Multiple Prenatal Screen, a new diagnostic test capable of performing four prenatal genetic screens simultaneously from a single maternal blood draw as early as eight weeks gestation. The test integrates fetal chromosome, fetal single-gene, patient carrier, and fetal RhD …

Clear Street Maintains MYR Group(MYRG.US) With Buy Rating, Raises Target Price to $530

Clear Street has reiterated its Buy rating on MYR Group (MYRG.US) and increased its target share price to $530. This update indicates a strong positive outlook from the analytical firm regarding the company's future performance.

Burning Rock and Myriad Announce Global Strategic Technology Licensing Partnership to Expand HRD Testing Worldwide

Burning Rock Biotech and Myriad Genetics have announced a global strategic technology licensing partnership to expand homologous recombination deficiency (HRD) testing worldwide. This collaboration will enhance Burning Rock's myChoice HRD Plus in China with a prostate Genomic Instability Score (prGIS) algorithm and allow Burning …

Emyria (ASX:EMD) Posts A$1.55M Revenue—Is the Healthcare Innovator Moving Closer to Commercial Scale?

Technical Reactions to MYRG Trends in Macro Strategies

This article analyzes Myr Group Inc. (NASDAQ: MYRG) using AI models, highlighting weak near and mid-term sentiment but a strong long-term outlook. It details specific trading strategies (Position, Momentum Breakout, Risk Hedging) with entry/target/stop-loss points and provides multi-timeframe signal analysis, including support and resistance …

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?

This article compares Aspira Women's Health Inc. (AWHL) and Myriad Genetics, Inc. (MYGN), two companies in the women's health diagnostics sector. While AWHL focuses on gynecologic diseases and is expanding its AI-powered diagnostics portfolio, MYGN offers a more diversified portfolio across oncology, women's health, …

ETFs Investing in Myriad Genetics, Inc. Stocks

This article lists various ETFs that hold Myriad Genetics, Inc. stocks, providing key financial data for each. The funds are sorted by market value and include details such asissuer, management style, focus, expense ratio, AUM, price, and 3-year NAV total return. The ETFs offer …

At US$415, Is MYR Group Inc. (NASDAQ:MYRG) Worth Looking At Closely?

This article evaluates MYR Group Inc. (NASDAQ:MYRG) from a valuation perspective, considering its current share price of US$415. The assessment aims to determine if the stock is a good value, factoring in earnings growth and future prospects.

MYR Group (MYRG) Sets Earnings Date As Investors Ask If Grid Growth Is Already Priced In

MYR Group (MYRG) has announced its second-quarter earnings release for July 29, 2026. While

MYR Group sets Q2 2026 earnings release and conference call

MYR Group Inc. announced it will release its second quarter 2026 financial results on July 29, 2026, after market close, with a conference call scheduled for July 30, 2026, at 8 a.m. Mountain Time. The company, a holding entity for specialty contractors in electric …

MYR Group Schedules Its 8 a.m. July 30 Earnings Webcast

MYR Group (NASDAQ: MYRG) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after market close. The company will host a conference call and simultaneous audio-only webcast to discuss these results on Thursday, July 30, 2026, at 8 …

Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation

Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

Emyria (ASX:EMD) Positions for Empax Growth with Victorian Patient Rollout

Myriad Genetics’s Q1 Earnings Call: Our Top 5 Analyst Questions

Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates

Myriad Genetics (MYGN) To Report Earnings Tomorrow: Here Is What To Expect

Is MYR Group (MYRG) Overvalued After Q1 2026 Earnings Beat? EPS

MYR Group (MYRG) Q1 Earnings and Revenues Top Estimates

Analysts Estimate Myriad Genetics (MYGN) to Report a Decline in Earnings: What to Look Out for

Small-Cap Stocks: Krispy Kreme, Myriad Genetics, and Hamilton Insurance Group to Avoid - News and Statistics

Will MYR (MYRG) Beat Estimates Again in Its Next Earnings Report?

MYR Group (MYRG) Earnings Expected to Grow: Should You Buy?

MYR Group Inc. Announces First Quarter 2026 Earnings Release and Conference Call Schedule

Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Myriad Genetics And 2 Other Penny Stocks To Watch Closely

Emyria (ASX:EMD) Shares Under Pressure Despite Expansion-Driven Growth Update

Myriad Genetics Beats Q4 Expectations, Shares Surge Amid Core Franchise Growth

Little Excitement Around Myriad Genetics, Inc.'s (NASDAQ:MYGN) Revenues As Shares Take 27% Pounding

Myer Holdings Limited's (ASX:MYR) largest shareholders are individual investors who were rewarded as market cap surged AU$112m last week

Emyria Limited (ASX: EMD) - Announcements

Emyria Limited (ASX:EMD)

Emyria Limited (EMD.AX) stock price, news, quote and history